Top ▲
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 615 | 5q35.3 | F12 | coagulation factor XII | |
Mouse | - | 597 | 13 B1 | F12 | coagulation factor XII (Hageman factor) | |
Rat | - | 595 | 17p14 | F12 | coagulation factor XII |
Previous and Unofficial Names |
factor XII | FXII | HAF | hageman factor | coagulation factor XII (Hageman factor) |
Database Links | |
Specialist databases | |
MEROPS | S01.211 (Hs) |
Other databases | |
Alphafold | P00748 (Hs), Q80YC5 (Mm), D3ZTE0 (Rn) |
BRENDA | 3.4.21.38 |
CATH/Gene3D | 2.10.10.10 |
ChEMBL Target | CHEMBL2821 (Hs) |
Ensembl Gene | ENSG00000131187 (Hs), ENSMUSG00000021492 (Mm), ENSRNOG00000015139 (Rn) |
Entrez Gene | 2161 (Hs), 58992 (Mm), 306761 (Rn) |
Human Protein Atlas | ENSG00000131187 (Hs) |
KEGG Enzyme | 3.4.21.38 |
KEGG Gene | hsa:2161 (Hs), mmu:58992 (Mm), rno:306761 (Rn) |
OMIM | 610619 (Hs) |
Orphanet | ORPHA121663 (Hs) |
Pharos | P00748 (Hs) |
RefSeq Nucleotide | NM_000505 (Hs), NM_021489 (Mm), NM_001014006 (Rn) |
RefSeq Protein | NP_000496 (Hs), NP_067464 (Mm), NP_001014028 (Rn) |
UniProtKB | P00748 (Hs), Q80YC5 (Mm), D3ZTE0 (Rn) |
Wikipedia | F12 (Hs) |
Enzyme Reaction | ||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
Inhibitor Comments | |||||||||||||||||||||||||||||||||||||||||||||||||||
Factor XIIa blocking antibody 3F7 is an inhibitor of FXIIa. |
Antibodies | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Immuno Process Associations | ||
|
||
|
Clinically-Relevant Mutations and Pathophysiology | ||||||||||||||
|
||||||||||||||
|
1. Diamond SL. Factor XIIa 1536 HTS Dose Response Confirmation - BioAssay Summary. Accessed on 06/09/2013. Modified on 06/09/2013. PubChem, http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=852
2. Panousis C, Rayznam V, Nash A, Wilson M, Schmidbauer S, Nolte M. (2018) Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodies. Patent number: US9856325B2. Assignee: CSL Ltd, CSL Behring GmbH Deutschland. Priority date: 04/11/2016. Publication date: 04/06/2024.
3. Wang M, Xu P. (2021) Anti-fxii nanobody or antigen binding fragment thereof and use thereof. Patent number: WO2021253662A1. Assignee: Ningbo Kangshan Biotechnology Co., Ltd.. Priority date: 21/09/2020. Publication date: 23/12/2021.
S1: Chymotrypsin: coagulation factor XII. Last modified on 04/06/2024. Accessed on 04/10/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2361.